TerrAscend (OTCMKTS:TSNDF) & Senestech (NASDAQ:SNES) Head-To-Head Contrast

TerrAscend (OTCMKTS:TSNDF) and Senestech (NASDAQ:SNES) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk.

Profitability

This table compares TerrAscend and Senestech’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TerrAscend	-40.86%	-23.19%	-6.35%
Senestech	-289.01%	-150.93%	-111.41%

Valuation and Earnings

This table compares TerrAscend and Senestech”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TerrAscend	$306.68 million	0.65	-$80.23 million	($0.41)	-1.59
Senestech	$1.86 million	8.21	-$6.18 million	($5.44)	-0.57

Senestech has lower revenue, but higher earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than Senestech, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and price targets for TerrAscend and Senestech, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TerrAscend	0	0	0	2	4.00
Senestech	1	1	0	1	2.33

Senestech has a consensus target price of $10.00, suggesting a potential upside of 223.62%. Given Senestech’s higher probable upside, analysts clearly believe Senestech is more favorable than TerrAscend.

Volatility and Risk

TerrAscend has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500. Comparatively, Senestech has a beta of 0.36, indicating that its stock price is 64% less volatile than the S&P 500.

Institutional & Insider Ownership

5.8% of TerrAscend shares are held by institutional investors. Comparatively, 5.2% of Senestech shares are held by institutional investors. 32.2% of TerrAscend shares are held by company insiders. Comparatively, 5.3% of Senestech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

TerrAscend beats Senestech on 10 of the 14 factors compared between the two stocks.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

About Senestech

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.